Literature DB >> 12906328

Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Andrew M Jones1, A Kevin Webb.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12906328      PMCID： PMC1308790     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  57 in total

Review 1.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.

Authors:  S S Pedersen; C Koch; N Høiby; K Rosendal
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

3.  Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.

Authors:  A Agodi; E Mahenthiralingam; M Barchitta; V Gianninò; A Sciacca; S Stefani
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

4.  Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.

Authors:  C Segonds; T Heulin; N Marty; G Chabanon
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

5.  Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp--a molecular-epidemiological study.

Authors:  K P Hunfeld; C Schmidt; B Krackhardt; H G Posselt; J Bargon; Y Yahaf; V Schäfer; V Brade; T A Wichelhaus
Journal:  Wien Klin Wochenschr       Date:  2000-04-07       Impact factor: 1.704

6.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

Authors:  P Vandamme; B Holmes; M Vancanneyt; T Coenye; B Hoste; R Coopman; H Revets; S Lauwers; M Gillis; K Kersters; J R Govan
Journal:  Int J Syst Bacteriol       Date:  1997-10

7.  Acute severe deterioration in cystic fibrosis associated with influenza A virus infection.

Authors:  S P Conway; E J Simmonds; J M Littlewood
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

8.  An epidemic Burkholderia cepacia complex strain identified in soil.

Authors:  John J LiPuma; Theodore Spilker; Tom Coenye; Carlos F Gonzalez
Journal:  Lancet       Date:  2002-06-08       Impact factor: 79.321

9.  Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

Authors:  K Cheng; R L Smyth; J R Govan; C Doherty; C Winstanley; N Denning; D P Heaf; H van Saene; C A Hart
Journal:  Lancet       Date:  1996-09-07       Impact factor: 79.321

10.  Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic.

Authors:  J Zimakoff; N Høiby; K Rosendal; J P Guilbert
Journal:  J Hosp Infect       Date:  1983-03       Impact factor: 3.926
View more
  6 in total

1.  Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach.

Authors:  Libor Fila; Pavel Dřevínek
Journal:  Folia Microbiol (Praha)       Date:  2017-03-31       Impact factor: 2.099

2.  Saturation mutagenesis of a CepR binding site as a means to identify new quorum-regulated promoters in Burkholderia cenocepacia.

Authors:  Yuping Wei; Gina T Ryan; Ana L Flores-Mireles; Esther D Costa; David J Schneider; Stephen C Winans
Journal:  Mol Microbiol       Date:  2011-02       Impact factor: 3.501

3.  A LuxR-type repressor of Burkholderia cenocepacia inhibits transcription via antiactivation and is inactivated by its cognate acylhomoserine lactone.

Authors:  Gina T Ryan; Yuping Wei; Stephen C Winans
Journal:  Mol Microbiol       Date:  2012-11-19       Impact factor: 3.501

4.  Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran.

Authors:  Z Movahedi; B Pourakbari; S Mahmoudi; F Sabouni; M T Ashtiani Haghi; R Hosseinpour Sadeghi; S Mamishi
Journal:  J Prev Med Hyg       Date:  2013-03

5.  Genome insights from the identification of a novel Pandoraea sputorum isolate and its characteristics.

Authors:  Rui-Fang Gao; Ying Wang; Ying Wang; Zhi-Wen Wang; Gui-Ming Zhang
Journal:  PLoS One       Date:  2022-08-05       Impact factor: 3.752

Review 6.  Home versus hospital intravenous antibiotic therapy for cystic fibrosis.

Authors:  Albert Balaguer; Javier González de Dios
Journal:  Cochrane Database Syst Rev       Date:  2015-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.